Saturday, May 23, 2015 6:39:26 AM
Dr. Pierce's goal from the beginning was a Combo IL12+Keytruda via EP treatment. $ONCS's 1200 to 1400 watts EP opens up the cancer's protective walls forcing immunogenicity factors to enter and transmit messengers back to one's body central control that then send out NK cells to destroy cancer the enemy.
$ONCS EP+IL12 is a producer of CD8 TILs, immunogenicity biologic component. The EP would also increase the penetration of Keytruda. Thereby the immunogenicty factors working in synchronous harmony producing more NKs resulting in increased ORR destroying more cancer than either IL12 or Keytruda alone. For Dr. Pierce a dream fruition materializing.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM